SCHEMBL7552785

SCHEMBL7552785

CCCCOC(=O)NCC(S)Cc1ccccn1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 4/20 0.49
▸ NPC1 O15118 3/20 0.49
▸ RAB9A P51151 3/20 0.49
▸ HPGD P15428 1/20 0.49
▸ HSD17B10 Q99714 1/20 0.49
▸ LMNA P02545 1/20 0.49
▸ GAA P10253 1/20 0.42
▸ HDAC6 Q9UBN7 4/20 0.41
▸ HDAC1 Q13547 2/20 0.41
▸ CTSK P43235 1/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ NAAA Q02083 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ PTPRA P18433 1/20 0.40
▸ CYP1A2 P05177 2/20 0.39
▸ CYP2C19 P33261 2/20 0.39
▸ PGR P06401 1/20 0.39
▸ ADORA3 P0DMS8 1/20 0.39
▸ PTGS1 P23219 1/20 0.39
▸ SLC6A2 P23975 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8507123 0.81 HPGD (0.67) SMN1; SMN2RAB9AHPGDHSD17B10CTSK
SCHEMBL7545282 0.81 SMN1; SMN2 (0.51) SMN1; SMN2NPC1RAB9AHPGDHSD17B10
SCHEMBL30890579 0.80 HPGD (0.65) SMN1; SMN2RAB9AHPGDHSD17B10GAA
SCHEMBL6440706 0.79 HPGD (0.54) SMN1; SMN2NPC1RAB9AHPGDHSD17B10
SCHEMBL5086307 0.78 HDAC6 (0.49) HPGDHSD17B10HDAC6HDAC1CTSK
SCHEMBL16118686 0.75 HSD17B10 (0.49) HPGDHSD17B10HDAC6HDAC1ALDH1A1
SCHEMBL9694059 0.73 HPGD (0.56) SMN1; SMN2NPC1RAB9AHPGDHSD17B10
SCHEMBL9695556 0.73 HPGD (0.56) SMN1; SMN2NPC1RAB9AHPGDHSD17B10
SCHEMBL9691525 0.73 HPGD (0.56) SMN1; SMN2NPC1RAB9AHPGDHSD17B10
SCHEMBL9695155 0.73 HPGD (0.56) SMN1; SMN2NPC1RAB9AHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1212301-A1 ARYLALKYLOXYALKYLAMINES AND ARYLALKYLTHIOALKYLAMINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE AS INHIBITORS OF NICOTINIC CHOLINERGIC RECEPTORS Targacept, Inc. (US) 2002-06-12 — — EP disclosed
WO-2001016107-A1 ARYLALKYLOXYALKYLAMINES AND ARYLALKYLTHIOALKYLAMINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE AS INHIBITORS OF NICOTINIC CHOLINERGIC RECEPTORS TARGACEPT, INC. (US) 2001-03-08 — — WO disclosed
Send feedback